In Brief: Rextovy — Another OTC Naloxone Nasal Spray

The FDA has approved the over-the-counter (OTC) sale of Rextovy (Amphastar), a nasal spray formulation of the opioid antagonist naloxone, for emergency treatment of opioid overdose.1 Other naloxone nasal sprays (Narcan, and generics; RiVive) are also available OTC (see Table 1).

Publication Details

Journal
˜The œmedical letter on drugs and therapeutics/˜The œmedical letter
Published
2026-08-24
DOI
https://doi.org/10.58347/tml.2026.1762d
Primary Topic
Respiratory and Cough-Related Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In Brief: Rextovy — Another OTC Naloxone Nasal Spray

˜The œmedical letter on drugs and therapeutics/˜The œmedical letter
Respiratory and Cough-Related Research
article

In Brief: Rextovy — Another OTC Naloxone Nasal Spray

article en

Abstract

The FDA has approved the over-the-counter (OTC) sale of Rextovy (Amphastar), a nasal spray formulation of the opioid antagonist naloxone, for emergency treatment of opioid overdose.1 Other naloxone nasal sprays (Narcan, and generics; RiVive) are also available OTC (see Table 1).

˜The œmedical letter on drugs and therapeutics/˜The œmedical letterVol. 68(1762)
Openalex Percentile: Top 11%
Respiratory and Cough-Related Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

In Brief: Rextovy — Another OTC Naloxone Nasal Spray · ˜The œmedical letter on drugs and therapeutics/˜The œmedical letter (2026) | TGRS Research Map | TGRS